Hospital investors are entering the second half of 2026 with a relatively clear priority: prove that operating performance can translate into earnings.
AI-powered diagnostics, remote monitoring, automation platforms, and virtual care solutions have attracted billions in investment and generated thousands of startups.
Every cycle in digital health produces a new infrastructure layer.
Healthcare services M&A has entered a more selective phase.
Healthcare M&A Is Poised for a Recovery in 2026. The Industry Still Sees Three Structural Barriers Standing in the Way.
Margin protection in healthcare used to mean one thing: cut costs faster than revenue slows.
Healthcare leaders consistently cite regulation as both a safeguard and a source of operational drag.
No Single Culprit — Layered Pressures Are Driving Costs Higher
Healthcare dealmaking hasn’t stopped — but the playbook is clearly evolving.
In a market defined by higher rates, tighter capital, and increased regulatory scrutiny, healthcare M&A is no longer just about finding the right asset — it’s about managing complexity after the deal closes
